This isn’t the same drug that Trump received, of course. That came from Regeneron. But between the hype over Lilly’s announcement today and the growing possibility that the president has made a shockingly fast recovery after being treated with an antibody cocktail, public interest in this treatment will soon be off the charts.
Since the start of the pandemic, antibody drugs have been cracked up to be the medication with the most potential to limit deaths from COVID apart from a vaccine. We’ve waited seven months for them, but they’re — almost — here. Free advice for the president: If he really is intent on riding this “go about your lives” message on the virus all the way to Election Day, he should dress it up heavily in scientific trappings. Emphasize constantly that we’re on the brink of one potential gamechanger thanks to Lilly and Regeneron and that another, the vaccine, is just a few short months away. There’s reason for hope.
Being hopeful doesn’t mean you should walk around your workplace without a mask after testing positive for COVID, like certain people do, of course. It just means that the light at the end of the tunnel is getting bigger.